Girls who eat peanut butter are less likely to develop breast cancer by the time they turned 30, reveals study.
Research from Washington University and Harvard Medical School analyzed the health histories of 9,039 U.S. girls from 1996 to 2001, when they were between the ages of 9 and 15, and later from 2005 to 2010, when they were 18 to 30 years old, Fox News reported.
Breast Cancer Facts and Figures
Breast cancer is the most commonly diagnosed cancer in women and in 2007 - 1.7 million breast cancers were diagnosed in the world.
Advertisement
Senior author Dr. Graham Colditz, associate director for cancer prevention and control at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, said that the findings suggested that peanut butter could help reduce the risk of breast cancer in women.
Source: ANI
Quiz on Breast Cancer
Breast cancer is one of the leading causes of cancer deaths among women. It is often said that a woman who breast-feeds is at a lower risk of developing cancer compared to another who does not .Are these mere old wives tales or is there some truth in it? This quiz on breast cancer has all the details.
Advertisement
 Breast Self Examination - AnimationSlides and animation of Breast Self Examination for early detection of breast cancer lumps in women | Advertisement
|
Peanut Butter may Cut Heart Risk
A study from the Harvard Medical School is reporting that snacking on peanuts and peanut butter at least five days in a week may be able to reduce the risk of a heart attack.
Advertisement
Recommended Reading
Latest Cancer News
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
A ray of hope for glioma patients as targeted therapy boosts treatment duration.